On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...

Short interest in Madrigal Pharmaceuticals rose to a four-month high, Ortex data showed, as bearish positions increased ...

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced two-year results from the open-label arm of ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has demonstrated sustained efficacy in a late-stage trial of patients with ...

Containerization was born of and rendered possible a far-flung, closely linked international economy that solders China to Alameda County and innumerable other markets. Madrigal coining of the label ...

Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an ...

A community came together Tuesday night to pay their respects to a Hughson mother of two after she was found dead over the ...

The four filmmakers will receive personal guidance from accomplished creative advisors to develop their projects ...

Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...

Stanislaus County sheriff’s deputies found the bodies of one of their own, Sgt. Daniel Hutsell, and his wife, Dinella ...

The 10 On Your Side team went to Grafton High School as part of our Excellent Educators series, highlighting those in our ...

Madrigal Pharmaceuticals announced positive results from the Phase 3 MAESTRO-NAFLD-1 trial of their drug Rezdiffra, focusing on patients with compensated metabolic dysfunction-associated ...